Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer

被引：29

作者：

Zhigang Z. ^{[1
]}

Wenlv S. ^{[2
]}

机构：

[1] Department of Urology, Shantou University Medical College, Shantou, Guangdong

[2] Department of Urology, Hosp. of Shantou Univ. Med. College, Shantou, Guangdong

来源：

World Journal of Surgical Oncology | / 2卷 / 1期

关键词：

Neoplasm; Prostate; Prostate stem cell antigen (PSCA);

D O I：

10.1186/1477-7819-2-13

中图分类号：

学科分类号：

摘要：

Background: Prostate stem cell antigen (PSCA) is a recently defined homologue of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. The purpose of the present study was to examine the expression status of PSCA protein and mRNA in clinical specimens of human prostate cancer (Pca) and to validate it as a potential molecular target for diagnosis and treatment of Pca. Materials and Methods: Immunohistochemical (IHC) and in situ hybridization (ISH) analyses of PSCA expression were simultaneously performed on paraffin-embedded sections from 20 benign prostatic hyperplasia (BPH), 20 prostatic intraepithelial neoplasm (PIN) and 48 prostate cancer (Pca) tissues, including 9 androgen-independent prostate cancers. The level of PSCA expression was semiquantitatively scored by assessing both the percentage and intensity of PSCA-positive staining cells in the specimens. Then compared PSCA expression between BPH, PIN and Pca tissues and analysed the correlations of PSCA expression level with pathological grade, clinical stage and progression to androgen-independence in Pca. Results: In BPH and low grade PIN, PSCA protein and mRNA staining were weak or negative and less intense and uniform than that seen in HGPIN and Pca. There were moderate to strong PSCA protein and mRNA expression in 8 of 11 (72.7%) HGPIN and in 40 of 48 (83.4%) Pca specimens examined by IHC and ISH analyses, with statistical significance compared with BPH (20%) and low grade PIN (22.2%) samples (p < 0.05, respectively). The expression level of PSCA increased with high Gleason grade, advanced stage and progression to androgen-independence (p < 0.05, respectively). In addition, IHC and ISH staining showed a high degree of correlation between PSCA protein and mRNA overexpression. Conclusions: Our data demonstrate that PSCA as a new cell surface marker is overexpressed by a majority of human Pca. PSCA expression correlates positively with adverse tumor characteristics, such as increasing pathological grade (poor cell differentiation), worsening clinical stage and androgen-independence, and speculatively with prostate carcinogenesis. PSCA protein overexpression results from upregulated transcription of PSCA mRNA. PSCA may have prognostic utility and may be a promising molecular target for diagnosis and treatment of Pca. © 2004 Zhigang and Wenlv; licensee BioMed Central Ltd.

引用

页数：7

共 25 条

[1]

Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., David E., Wahl M., Nisitani S., Yamashiro J., Le Beau M.M., Loda M., Witte O.N., Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer, Proc. Natl. Acad. Sci. USA, 95, pp. 1735-1740, (1998)

[2]

Gleason D.F., Histologic grading and clinical staging of prostatic carcinoma, Urologic Pathology: The Prostate, pp. 171-197, (1977)

[3]

Brawer M.K., Prostatic intraepithelial neoplasia: A premalignant lesion, Hum. Pathol., 23, pp. 242-248, (1992)

[4]

Amin M.B., Ro J.Y., Ayala A.C., Prostatic intraepithelial neoplasia: Relationship to adenocarcinoma of prostate, Pathol. Annu., 29, pp. 1-30, (1994)

[5]

Amara N., Palapattu G.S., Schrage M., Gu Z., Thomas G.V., Dorey F., Said J., Reiter R.E., Prostate stem cell antigen is overexpressed in human transitional cell carcinoma, Cancer Res., 61, pp. 4660-4665, (2001)

[6]

Hanas J.S., Lerner M.R., Lightfoot S.A., Raczkowski C., Kastens D.J., Brackett D.J., Postier R.G., Expression of the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus, Cancer (Phila), 86, pp. 756-763, (1999)

[7]

Egevad L., Gramfors T., Karlberg L., Prognostic value of the Gleason score in prostate cancer, BJU Int., 89, pp. 538-542, (2002)

[8]

Tran C.P., Lin C., Yamashiro J., Reiter R.E., Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells, Mol. Cancer Res., 1, pp. 113-121, (2002)

[9]

Gu Z., Thomas G., Yamashiro J., Shintaku I.P., Dorey F., Raitano A., Witte O.N., Said J.W., Loda M., Reiter R.E., Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer, Oncogene, 19, pp. 1288-1296, (2000)

[10]

Han K.R., Seligson D.B., Liu X., Horvath S., Shintaku P.I., Thomas G.V., Said J.W., Reiter R.E., Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer, J. Urol., 171, pp. 1117-1121, (2004)

← 1 2 3 →